Get started

BFLY

BFLY Price Target $20BFLY Current Price $12.20 Price Target $20 I like BFLY here, as it has over $500 million in cash following its merger with Longview, and I like that it is fully expected to be cash-flow positive by 2024.Revenue increased 40.0% to $16.5 million in Q2 2021 from $11.8 million in Q2 2020. The revenue can be traced to both product and subscription revenues. Product revenue increased 30.3% to $13.0 million from $10.0 million last year. That is solid. The company is focused heavily on improving subscriptions, and it is translating to sales. Subscription revenue increased 94.3% to $3.5 million from $1.8 million last year. I see this line of revenue growing sizably in the coming quarters as it becomes a bigger focus of the company. With a half of billion in cash BFLY has significant funds to continue growing their customer base with their innovative cost cutting products. Their Butterfly IQ+ is a handheld ultrasound which is cutting the cost of ultrasounds by over 90%, this opens up the opportunity for the company to expand to developing countries with this amazing cost cutting innovation.
NYSE:BFLYLong
by Value-Invest
BFLY Should Hold SupportBFLY Current Price $12.75 Price Target $20 This company is a fairly valued (5x PE) innovative healthcare company. Butterfly Networks is cutting the cost of ultrasounds by 90% with their handheld device, the new ultrasound platform uses a semiconductor rather than a crystal based sound wave. They are targeting emerging markets with this amazing cost cutting innovation. It hasn’t been a better time to buy BFLY in quite some time as BFLY is now trading on crucial support around $12.50. I think we hold this support line and trade up to the top line of resistance around $15 within the next couple months then we should move up to $20 in the coming months.
NYSE:BFLYLong
by Value-Invest
1
BFLY Price Target $25BFLY Current Price $14.36 Price Target $20 $10c 10/15 ($470, 3% till breakeven) We have been in BFLY since $10. This company is a fairly valued (5x PE) innovative healthcare company. Butterfly Networks is cutting the cost of ultrasounds by 90% with their handheld device, the new ultrasound platform uses a semiconductor rather than a crystal based sound wave. They are targeting emerging markets with this amazing cost cutting innovation. We saw insiders buy over 2 million worth of shares earlier this month, which signifies confidence of the business within the company. This is a long term hold for me!
NYSE:BFLYLong
by Value-Invest
BFLY Finding New Support LevelButterfly Network Inc. $BFLY Current Price $13.27 Price Target $20 BFLY $10c 10/15 ($390,4% till breakeven) BFLY has created a handheld ultrasound which can be sold for as low as $2,000 cutting the average price by 90%. This company is young but it is less speculative than most early-stage disruptive companies as BFLY is already selling its product. Given their low barrier to entry and existing product they expect to grow revenue at over 60% for the next four years. This is a long-term hold and you have to believe in the product and the management if you are to invest. However, this pullback may be the best valuation to capture this company's future growth, which is less of an if and more of a when.Butterfly Networks is confirming a new trading range with support at $12.80 which I do expect to hold.
NYSE:BFLYLong
by Value-Invest
BFLY On The Way To $20BFLY Current Price $11.75 Price Target $20 Innovative tech has been killed since February but the core difference between most innovative tech and BFLY is BFLY is a profitable company only trading at 5xPE. This is very cheap when you consider the S&P is trading at 20 PE (which means BFLY is trading four times cheaper than the market). BFLY has created a handheld ultrasound that is significantly cheaper than a normal ultrasound machine. This product is going to be used by developing countries in the future.
NYSE:BFLYLong
by Value-Invest
2
BFLY HITTING SUPPORT - $20 PRICE TARGETBFLY - Current Price $ 10.23 Price Target (short-term) $12.50 Long Term $20 This company created an Ultra sound that is hand held and can give you the same images and accuracy as the ones in use in the USA. The best part about the innovation is the cost reduction. These cost under 3k while most ultra sounds cost a million +. This innovative tech will be used to bring this technology to poorer developing countries. Just reported $0.57 EPS last quarter on an annual basis that would be a PE of 4.5x which is cheap given the growth prospects for this company. Looks great on the chart as we are seeing a double bottom off that $9.80 level. Long shares and calls here.
NYSE:BFLYLong
by Value-Invest
BFLY update.I had previously put this on a watchlist for going long. Now, I am actually thinking it's going to fall further. I thought at this point the wedge breakout would have occurred, and since buyers haven't moved in, I think it may be headed down further. I have seen similar setups where the wedge keeps getting tighter and tighter on the top, then finally no buyers are to be found and price plummets. I'm not saying this is going to happen.. but if market makers are trying to hide their intention to buy they are doing it strictly and collectively. I think I will steer clear of trading this, but I do enjoy a good case study, especially when it's not being done on me, so let's see what's in the cards.
NYSE:BFLY
by emehoke
1
Butterfly Network to merge with SPAC Longview The combined company will list on the New York Stock Exchange under the ticker "BFLY." It will have about $584 million in cash to develop its digital imaging technology. Butterfly's early investors include Baillie Gifford, The Bill and Melinda Gates Foundation and Fosun Industrial Co., Limited. Butterfly's aim is to make superior medical imaging at more affordable prices. The deal is expected to close in the first quarter of 2021. (marketwatch) If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
LLong
by TopgOptions